PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
Sorona® and WGSN Announce Top Bio-Based Material Trends of 2027
Bio-based materials emerge as a leading trend shaping the future of fashion across athleisure and luxury ready-to-wear apparel ...
2026-07-29T    Biotechnology   Fashion   Household/Consumer/Cosmetics   Textiles 
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian ...
2026-07-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology
The global launch brings image-based morphology intelligence into routine hematology workflows through AI × CBM technology. ...
2026-07-29T    Biotechnology   Health Care/Hospital   Medical Equipment 
LabAsia Returns to Borneo Amid Rising Demand for Laboratory Technologies
East Malaysia hosts Southeast Asia's leading laboratory exhibition as investment in research, healthcare and advanced manufacturing continues to grow. ...
2026-07-28T    Biotechnology   Chemical   Medical Equipment   Trade show news 
Torrey Pines Medicine Secures Angel Round to Advance Next-Generation Ultra-Long-Acting Peptide Therapeutics
Led by Lotus Lake Capital, the financing will accelerate the development of TPM004, a differentiated ultra-long-acting amylin/calcitonin receptor dual agonist, and advance the company's proprietary PepTetris™ ...
2026-07-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
IHH Healthcare Expands 'IHH Catalyst' to North Asia to Accelerate Clinical Adoption of Healthcare Innovation
Building on the success of its inaugural programme in India, IHH Healthcare is launching IHH Catalyst | North Asia Edition to help startups in Hong Kong, Chinese Mainland and neighbouring markets turn ...
2026-07-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Everest Medicines Announces Participation in Upcoming Investor Conferences
SHANGHAI , July 27, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ...
2026-07-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem
SHANGHAI , July 27, 2026 /PRNewswire/ --  AsymBio , a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of  Asymchem Group  (stock codes: 002821.SZ ...
2026-07-27T    Biotechnology   Construction/Building   Health Care/Hospital   Medical/Pharmaceuticals 
Pictor Debuts New PictImager® at ADLM 2026 to Make Targeted Protein Analysis More Practical
Beta-site engagement begins as Pictor introduces an integrated 96-well workflow designed for scalable targeted protein analysis in research laboratories. ...
2026-07-27T    Biotechnology 
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
TAIPEI , July 27, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and ...
2026-07-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.